tiprankstipranks
Sinopharm Tech Holdings Limited (HK:8156)
:8156
Hong Kong Market

Sinopharm Tech Holdings Limited (8156) Financial Statements

Compare
0 Followers

Sinopharm Tech Holdings Limited Financial Overview

Sinopharm Tech Holdings Limited's market cap is currently HK$70.34M. The company's EPS TTM is HK$-0.109; its P/E ratio is ―; Sinopharm Tech Holdings Limited is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueHK$ 41.28MHK$ 42.84MHK$ 40.98MHK$ 77.81MHK$ 165.93M
Gross ProfitHK$ 5.02MHK$ 5.47MHK$ 5.93MHK$ 20.88MHK$ 44.65M
Operating IncomeHK$ 0.00HK$ -186.00KHK$ -74.62MHK$ -55.85MHK$ -25.95M
EBITDAHK$ 4.98MHK$ -1.01MHK$ -75.17MHK$ -89.65MHK$ -138.51M
Net IncomeHK$ -19.70MHK$ -10.63MHK$ -88.00MHK$ -106.34MHK$ -161.07M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 2.64MHK$ 1.78MHK$ 2.99MHK$ 7.48MHK$ 6.75M
Total AssetsHK$ 44.49MHK$ 33.48MHK$ 76.89MHK$ 135.90MHK$ 188.17M
Total DebtHK$ 73.26MHK$ 0.00HK$ 45.93MHK$ 108.03MHK$ 117.42M
Net DebtHK$ 70.62MHK$ -1.78MHK$ 42.94MHK$ 100.55MHK$ 110.67M
Total LiabilitiesHK$ 250.09MHK$ 213.24MHK$ 250.28MHK$ 276.46MHK$ 261.56M
Stockholders' EquityHK$ -199.48MHK$ -172.73MHK$ -166.78MHK$ -138.88MHK$ -73.08M
Cash Flow
Free Cash FlowHK$ -12.58MHK$ 4.73MHK$ -36.88MHK$ -16.32MHK$ 523.00K
Operating Cash FlowHK$ -9.25MHK$ 4.73MHK$ -36.76MHK$ -6.21MHK$ 23.92M
Investing Cash FlowHK$ -4.86MHK$ 2.00KHK$ -85.00KHK$ -5.05MHK$ -23.39M
Financing Cash FlowHK$ 14.98MHK$ -4.52MHK$ 32.24MHK$ 12.46MHK$ -299.00K
Currency in HKD

Sinopharm Tech Holdings Limited Earnings and Revenue History

Sinopharm Tech Holdings Limited Debt to Assets

Sinopharm Tech Holdings Limited Cash Flow

Sinopharm Tech Holdings Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis